Bacillus Subtilis Market

Global Bacillus Subtilis Market by Forms, (Liquid, Powder, and Paste) by Product Types, (<100 billion CFU/g, 100–300 billion CFU/g, > 300 billion CFU/g), by End Use Industry (Pharmaceutical Industry, Food & Beverage Industry, Agriculture Industry, Livestock Industry, and Others), and by Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Report ID: MC-2563
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 244
  • Format:
  • Pub. Date: 02-06-2021
  • Share:

Market Outlook:

The global bacillus subtilis market was valued at USD 71.2 Million in 2019 and is projected to reach USD 125.9 Million by 2027, expanding at a CAGR of 7.8% during the forecast period. Bacillus subtilis is a fast-growing gram-positive aerobic bacterium and is found in soil and water. The rod-shaped cells are usually 2–6 µm in length and slightly less than 1 µm in diameter. The optimal growth temperature is between 30-35°C and the doubling time is only 20 minutes. Under certain growth conditions, cells tend to form long chains, which are connected by unbroken wall material. Under starvation conditions, cells undergo a complex process of cell differentiation, leading to the formation of endospores, which are released through cell membrane lysis, stem cell.

Bacillus Subtilis Market Key Takeaways

Vegetative cells are mobile. They form biofilms and "fruiting bodies" of spores. Bacillus subtilis releases a variety of enzymes to break down various substrates and enables bacteria to survive in a constantly changing environment. B. subtilis has a long history and was first described in the 19th century. This bacterium was originally called Vibrio subtilis and discovered in 1835 by Christian Gottfried Ehrenberg. It is first described in detail and renamed in 1872 by Ferdinand Cohn. This bacterium is now known as Bacillus subtilis. Experiments in the late 1950s confirmed its position in the history of genetics and experiments showed that it used linear DNA for natural transformation.

Market Dynamics

Beneficial in combating infections

Bacteriocin from Bacillus subtilis inhibits the growth of various pathogens. Bacillus subtilis reduces the incidence of respiratory infections in the elderly. Bacillus subtilis, isolated from soil, shows antibacterial activity against pathogenic human Candida albicans. Metabolites of bacillus subtilis reduce the resistance of pathogenic urogenital tract microbiota to antibiotics in patients with urinary tract infections, thereby speeding up their recovery. It reduces the symptoms of clostridium difficile infection in mice. B. subtilis inhibits infection and enteropathy in suckling mice infected with C. rodentium. Hence, the benefits of bacillus subtills in combating infections in humans and animals is driving the market during the forecast period.

Increasing demand for Bacillus Subtilis due to its anti-oxidant properties

Bacillus subtilis has protective and anti-oxidant activity against DNA. A signal molecule from Bacillus subtilis induces the heat shock protein, Hsp27 in mammalian cells, which protects intestinal cells from oxidant-mediated tissue damage and loss of barrier function. Anti-oxidant properties benefit humans undergoing stress-related activities. Hence, increasing demand for bacillus subtilis, due to its anti-oxidant properties, is driving the market during the forecast period.

Lack of awareness among consumers about the effectiveness of Bacillus Subtilis

Various beneficial properties are associated with bacillus subtilis, which have a positive impact on humans, animals, and plants. It helps in reducing stress levels, increases immunity, improves liver disorders, and reduces the risk of cancer in humans. It helps in preventing nausea, vomiting, abdominal pain, and diarrhea. Most people do not know about these benefits, which reduces the demand for B. subtilis and adversely affects the sales. Hence, lack of consumer awareness about bacillus subtilis hampers the market growth during the forecast period.

Increasing Investments in Bacillus Subtilis-based product development

Companies are adopting various strategies to gain competitive advantages. Key players are focusing on product development, which increases the demand for bacillus subtilis. BASF SE launched a new product range, named Velondis, which is a biofungicide seed treatment agent, which was registered with the US Environmental Protection Agency (EPA) in January 2018. Velondis incorporates a unique stain of Bacillus subtilis, which protects seedlings and plants from soil-borne diseases. Deerland Enzymes, Inc. introduced a new, more soluble probiotic strain, Bacillus subtilis DE111. This spore-forming probiotic is easily soluble in natural foods and used in hot beverages, functional drinks, and dietary supplements.

Bacillus subtilis has multiple health benefits for humans, animals, and plants and thus it is an attractive probiotic species for various clinical conditions. It is used as an important ingredient in many industries such as pharmaceutical, food & beverage, livestock, wastewater management, agriculture, and industrial chemical. Governments around the globe have issued various rules and regulations for the registration, production, and use of bacillus subtilis. For production various precautionary measures are adopted to reduce the risk of adverse effects on the workers. Bacillus subtilis strains are used as antigen that carry bacterial vaccines and cells to produce antigens.

Segmental Outlook

By Type Segment

Based on forms, the global bacillus subtilis market is divided into liquid, powder, and paste. Liquid bacillus subtilis is used in the food & beverage industry, the pharmaceutical industry, and the bio-chemical industry. Bacillus subtilis powder is used in the agriculture industry and as cattle feeding. Bacillus subtilis paste is used in the bio-chemical industry.

Bacillus Subtilis Market By Forms

By Product Types Segment

In terms of product types, the global bacillus subtilis market is classified into <100 billion CFU/g, 100–300 billion CFU/g, and > 300 billion CFU/g. The effectiveness of probiotics is expressed in CFU or colony-forming unit, which is a unit of measurement used in microbiology to estimate the number of bacteria that can divide and form colonies in a sample, although most positive clinical studies indicate a probiotic dose of 10 to 20 billion CFU per day is enough to maintain a healthy digestive system and immunity, and 50 to 100 billion CFU products are becoming more common. Bacillus subtilis products are measured in billion CFU/g.

Bacillus Subtilis Market By Product Types

By End Use Industry Segment

In terms of applications, the global bacillus subtilis market is classified into pharmaceutical, food & beverage, agriculture, livestock, and others. The food & beverage industry is expected to hold a significant market share during the forecast period owing to its various health benefits such as improved liver disorder, reduced risk of cancer, protection against infections and allergies, and decreased obesity.

Region Wise Outlook

Based on regions, the global bacillus subtilis market is fragmented into North America, Europe, Latin America, and Middle East & Africa. Growing demand for high-purity Bacillus subtilis in countries such as Japan, China, and India have led to the substantial growth of the Bacillus subtilis market in Asia Pacific. Probiotic beverage formulations containing Bacillus subtilis are popular in South Korea and Japan. Latin America and the Middle East & Africa are expected to hold a significant share of the market during the forecast period. The demand for Bacillus subtilis is expected to rise in key industries such as pharmaceuticals, food processing, and beverages in these regions. Increasing demand for non-toxic bacterial products and changes in consumer preferences that are estimated to fuel the demand for Bacillus subtilis in the near future.

Bacillus Subtilis Market By Regions

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Bacillus Subtilis Market
  • Historical, Current and Projected Market Size in terms of Value
  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
  • Industry Drivers, Restraints and Opportunities Covered in the Study
  • Recent Industry Trends and Developments
  • Competitive Landscape & Strategies of Key Players
  • Neutral Perspective on Global Bacillus Subtilis Market Performance

Segments

Key Segments Covered
By Form
  • Liquid
  • Powder
  • Paste
By Product Types
  • <100 billion CFU/g
  • 100–300 billion CFU/g
  • > 300 billion CFU/g
By End Use Industry
  • Pharmaceutical Industry
  • Food & Beverage Industry
  • Agriculture Industry
  • Livestock Industry
  • Others
By Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Market Players Profiled in the Report
  • Bayer AG
  • Deerland Probiotics & Enzymes, Inc
  • THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP)
  • Aumgene Biosciences
  • Wuhan Kernel Bio-tech Co., Ltd.
  • Meteoric Biopharmaceuticals Pvt. Ltd.
  • BASF SE
  • Manidharma Biotech Private Limited
  • Lonza
  • AgriLife
  • Anand Agro Care
  • Merck KGaA

Competitive Landscape

Key players in the market include Bayer AG, Deerland Probiotics & Enzymes, Inc, THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP), Aumgene Biosciences, Wuhan Kernel Bio-tech Co., Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., BASF SE, Manidharma Biotech Private Limited, Lonza, AgriLife, Anand Agro Care, and Merck KGaA. These players are considered as key manufacturers of the market based on different varieties of product availability, regional presence, better supply chain management system, and the increasing demand for the products. The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition and many other strategies to increase their demand for global bacillus subtilis market.

Bacillus Subtilis Market By Key Players

Video Summary for Bacillus Subtilis Market Market

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacillus Subtilis Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Bacillus Subtilis Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Bacillus Subtilis Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Bacillus Subtilis Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Bacillus Subtilis Market Size & Forecast, 2017-2027
      4.5.1 Bacillus Subtilis Market Size and Y-o-Y Growth
      4.5.2 Bacillus Subtilis Market Absolute $ Opportunity
   4.6 Global Bacillus Subtilis Market: Impact Of Key Regulations
   4.7 Technology Trends
Chapter 5 Global Bacillus Subtilis Market Analysis and Forecast By Form
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Form
      5.1.2 Basis Point Share (BPS) Analysis By Form
      5.1.3 Absolute $ Opportunity Assessment By Form
   5.2 Bacillus Subtilis Market Size Forecast By Form
      5.2.1 Liquid
      5.2.2 Powder
      5.2.3 Paste
   5.3 Market Attractiveness Analysis By Form
Chapter 6 Global Bacillus Subtilis Market Analysis and Forecast By Product Type
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Product Type
      6.1.2 Basis Point Share (BPS) Analysis By Product Type
      6.1.3 Absolute $ Opportunity Assessment By Product Type
   6.2 Bacillus Subtilis Market Size Forecast By Product Type
      6.2.1 <100 billion CFU/g
      6.2.2 100–300 billion CFU/g
      6.2.3 > 300 billion CFU/g
   6.3 Market Attractiveness Analysis By Product Type
Chapter 7 Global Bacillus Subtilis Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Bacillus Subtilis Market Size Forecast By Application
      7.2.1 Pharmaceutical Industry
      7.2.2 Food & Beverage Industry
      7.2.3 Agriculture Industry
      7.2.4 Livestock Industry
      7.2.5 Others
   7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Bacillus Subtilis Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Bacillus Subtilis Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Bacillus Subtilis Analysis and Forecast
   10.1 Introduction
   10.2 North America Bacillus Subtilis Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Bacillus Subtilis Market Size Forecast By Form
      10.6.1 Liquid
      10.6.2 Powder
      10.6.3 Paste
   10.7 Basis Point Share (BPS) Analysis By Form
   10.8 Absolute $ Opportunity Assessment By Form
   10.9 Market Attractiveness Analysis By Form
   10.10 North America Bacillus Subtilis Market Size Forecast By Product Type
      10.10.1 <100 billion CFU/g
      10.10.2 100–300 billion CFU/g
      10.10.3 > 300 billion CFU/g
   10.11 Basis Point Share (BPS) Analysis By Product Type
   10.12 Absolute $ Opportunity Assessment By Product Type
   10.13 Market Attractiveness Analysis By Product Type
   10.14 North America Bacillus Subtilis Market Size Forecast By Application
      10.14.1 Pharmaceutical Industry
      10.14.2 Food & Beverage Industry
      10.14.3 Agriculture Industry
      10.14.4 Livestock Industry
      10.14.5 Others
   10.15 Basis Point Share (BPS) Analysis By Application
   10.16 Absolute $ Opportunity Assessment By Application
   10.17 Market Attractiveness Analysis By Application
Chapter 11 Europe Bacillus Subtilis Analysis and Forecast
   11.1 Introduction
   11.2 Europe Bacillus Subtilis Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Bacillus Subtilis Market Size Forecast By Form
      11.6.1 Liquid
      11.6.2 Powder
      11.6.3 Paste
   11.7 Basis Point Share (BPS) Analysis By Form
   11.8 Absolute $ Opportunity Assessment By Form
   11.9 Market Attractiveness Analysis By Form
   11.10 Europe Bacillus Subtilis Market Size Forecast By Product Type
      11.10.1 <100 billion CFU/g
      11.10.2 100–300 billion CFU/g
      11.10.3 > 300 billion CFU/g
   11.11 Basis Point Share (BPS) Analysis By Product Type
   11.12 Absolute $ Opportunity Assessment By Product Type
   11.13 Market Attractiveness Analysis By Product Type
   11.14 Europe Bacillus Subtilis Market Size Forecast By Application
      11.14.1 Pharmaceutical Industry
      11.14.2 Food & Beverage Industry
      11.14.3 Agriculture Industry
      11.14.4 Livestock Industry
      11.14.5 Others
   11.15 Basis Point Share (BPS) Analysis By Application
   11.16 Absolute $ Opportunity Assessment By Application
   11.17 Market Attractiveness Analysis By Application
Chapter 12 Asia Pacific Bacillus Subtilis Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Bacillus Subtilis Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Bacillus Subtilis Market Size Forecast By Form
      12.6.1 Liquid
      12.6.2 Powder
      12.6.3 Paste
   12.7 Basis Point Share (BPS) Analysis By Form
   12.8 Absolute $ Opportunity Assessment By Form
   12.9 Market Attractiveness Analysis By Form
   12.10 Asia Pacific Bacillus Subtilis Market Size Forecast By Product Type
      12.10.1 <100 billion CFU/g
      12.10.2 100–300 billion CFU/g
      12.10.3 > 300 billion CFU/g
   12.11 Basis Point Share (BPS) Analysis By Product Type
   12.12 Absolute $ Opportunity Assessment By Product Type
   12.13 Market Attractiveness Analysis By Product Type
   12.14 Asia Pacific Bacillus Subtilis Market Size Forecast By Application
      12.14.1 Pharmaceutical Industry
      12.14.2 Food & Beverage Industry
      12.14.3 Agriculture Industry
      12.14.4 Livestock Industry
      12.14.5 Others
   12.15 Basis Point Share (BPS) Analysis By Application
   12.16 Absolute $ Opportunity Assessment By Application
   12.17 Market Attractiveness Analysis By Application
Chapter 13 Latin America Bacillus Subtilis Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Bacillus Subtilis Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Bacillus Subtilis Market Size Forecast By Form
      13.6.1 Liquid
      13.6.2 Powder
      13.6.3 Paste
   13.7 Basis Point Share (BPS) Analysis By Form
   13.8 Absolute $ Opportunity Assessment By Form
   13.9 Market Attractiveness Analysis By Form
   13.10 Latin America Bacillus Subtilis Market Size Forecast By Product Type
      13.10.1 <100 billion CFU/g
      13.10.2 100–300 billion CFU/g
      13.10.3 > 300 billion CFU/g
   13.11 Basis Point Share (BPS) Analysis By Product Type
   13.12 Absolute $ Opportunity Assessment By Product Type
   13.13 Market Attractiveness Analysis By Product Type
   13.14 Latin America Bacillus Subtilis Market Size Forecast By Application
      13.14.1 Pharmaceutical Industry
      13.14.2 Food & Beverage Industry
      13.14.3 Agriculture Industry
      13.14.4 Livestock Industry
      13.14.5 Others
   13.15 Basis Point Share (BPS) Analysis By Application
   13.16 Absolute $ Opportunity Assessment By Application
   13.17 Market Attractiveness Analysis By Application
Chapter 14 Middle East & Africa (MEA) Bacillus Subtilis Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Bacillus Subtilis Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Bacillus Subtilis Market Size Forecast By Form
      14.6.1 Liquid
      14.6.2 Powder
      14.6.3 Paste
   14.7 Basis Point Share (BPS) Analysis By Form
   14.8 Absolute $ Opportunity Assessment By Form
   14.9 Market Attractiveness Analysis By Form
   14.10 Middle East & Africa (MEA) Bacillus Subtilis Market Size Forecast By Product Type
      14.10.1 <100 billion CFU/g
      14.10.2 100–300 billion CFU/g
      14.10.3 > 300 billion CFU/g
   14.11 Basis Point Share (BPS) Analysis By Product Type
   14.12 Absolute $ Opportunity Assessment By Product Type
   14.13 Market Attractiveness Analysis By Product Type
   14.14 Middle East & Africa (MEA) Bacillus Subtilis Market Size Forecast By Application
      14.14.1 Pharmaceutical Industry
      14.14.2 Food & Beverage Industry
      14.14.3 Agriculture Industry
      14.14.4 Livestock Industry
      14.14.5 Others
   14.15 Basis Point Share (BPS) Analysis By Application
   14.16 Absolute $ Opportunity Assessment By Application
   14.17 Market Attractiveness Analysis By Application
Chapter 15 Competition Landscape
   15.1 Bacillus Subtilis Market: Competitive Dashboard
   15.2 Global Bacillus Subtilis Market: Market Share Analysis, 2020
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 AgriLife
      15.3.2 Anand Agro Care
      15.3.3 Aumgene Biosciences
      15.3.4 BASF SE
      15.3.5 Bayer AG
      15.3.6 Deerland Probiotics & Enzymes, Inc
      15.3.7 Lonza
      15.3.8 Manidharma Biotech Private Limited
      15.3.9 Merck KGaA
      15.3.10 Meteoric Biopharmaceuticals Pvt. Ltd.
      15.3.11 Real IPM UK
      15.3.12 Wuhan Kernel Bio-tech Co., Ltd.
Key Segments Covered
By Form
  • Liquid
  • Powder
  • Paste
By Product Types
  • <100 billion CFU/g
  • 100–300 billion CFU/g
  • > 300 billion CFU/g
By End Use Industry
  • Pharmaceutical Industry
  • Food & Beverage Industry
  • Agriculture Industry
  • Livestock Industry
  • Others
By Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Market Players Profiled in the Report
  • Bayer AG
  • Deerland Probiotics & Enzymes, Inc
  • THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP)
  • Aumgene Biosciences
  • Wuhan Kernel Bio-tech Co., Ltd.
  • Meteoric Biopharmaceuticals Pvt. Ltd.
  • BASF SE
  • Manidharma Biotech Private Limited
  • Lonza
  • AgriLife
  • Anand Agro Care
  • Merck KGaA

Key players in the market include Bayer AG, Deerland Probiotics & Enzymes, Inc, THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP), Aumgene Biosciences, Wuhan Kernel Bio-tech Co., Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., BASF SE, Manidharma Biotech Private Limited, Lonza, AgriLife, Anand Agro Care, and Merck KGaA. These players are considered as key manufacturers of the market based on different varieties of product availability, regional presence, better supply chain management system, and the increasing demand for the products. The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition and many other strategies to increase their demand for global bacillus subtilis market.

Bacillus Subtilis Market By Key Players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles can be provided on request.

According to this Growth Market Reports, report, the market from global bacillus subtilis market is likely to register a CAGR of 7.8% during period 2020-2027, with an anticipated valuation of USD 125.9 Mn by the end of the 2027.

In addition to market size (in USD Million) and Company Market Share (in % for base year 2019), other data such Macro-economic factors, Impact of key regulations on the market, technology trends, and COVID-19 Impact on the global bacillus subtilis market is available in final report.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The global bacillus subtilis market is anticipated to grow significantly during forecast period due beneficial in combating infections, rising demand for bacillus subtilis due to GI traits, increasing demand for bacillus subtilis due to its anti-oxidant properties, and benefits of bacillus subtilis for environment.

Pharmaceutical, food & beverage, agriculture, livestock, and others are few of the key end use industries driving the market growth.

The market is expected to witness growth at a fast pace with increase in terms of demand during 2019-2020 owing to the positive impact of COVID-19 pandemic on the global bacillus subtilis market.

The base year considered for the global bacillus subtilis market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years, 2020 is an estimated year and the forecast is provided from 2021 to 2027.

Major Manufactures include Bayer AG, Deerland Probiotics & Enzymes, Inc, THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP), Aumgene Biosciences, Wuhan Kernel Bio-tech Co., Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., BASF SE, Manidharma Biotech Private Limited, Lonza, AgriLife, Anand Agro Care, and Merck KGaA.